OPTEY
Opthea Ltd
$0.0250
-40.48%
No data for this timeframe.
Vol
Inst. Holders4 funds
Inst. Value$64.2K
Inst. Activity1 buys / 0 sells
Exchange OTC·Sector Biological Products, (No Diagnostic Substances)·Inc. C3·CIK 0001815620·Prev Close $0.0420
Recent Activity
Inst.
UBS Group AG — DOUBLED
18,073 shares ($61.6K)
Inst.
HSBC HOLDINGS PLC — TRIM
105,939 shares ($356.0K)
Analyst Ratings
0Strong Buy
0Buy
2Hold
4Sell
1Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BAKER BROS. ADVISORS LP | — | — |
| UBS Group AG | $61.6K | DOUBLED |
| MORGAN STANLEY | $2.6K | NEAR_EXIT |
| HSBC HOLDINGS PLC | $10.00 | TRIM |
4 institutional holders with $64.2K total value (2,212,097 shares) as of 2025-Q3. Top holders: BAKER, UBS, MORGAN. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 2,087,320 | $0.00 | 0.0% | — |
| 2 | UBS Group AG | 18,073 | $61.6K | 96.0% | DOUBLED +132.5% |
| 3 | MORGAN STANLEY | 765 | $2.6K | 4.0% | NEAR_EXIT -77.3% |
| 4 | HSBC HOLDINGS PLC | 105,939 | $10.00 | 0.0% | TRIM -25.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | DOUBLED | 7,773 | 18,073 | +132.5% | $61.6K | 2025-Q3 |
| HSBC HOLDINGS PLC | TRIM | 142,515 | 105,939 | -25.7% | $356.0K | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 36,757 | 7,773 | -78.9% | $26.5K | 2025-Q1 |
| MORGAN STANLEY | NEAR_EXIT | 3,365 | 765 | -77.3% | $2.6K | 2025-Q1 |
| UBS Group AG | DOUBLED | 2,388 | 36,757 | +1439.2% | $144.4K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 7 analysts — 0 strong buy, 0 buy, 2 hold, 4 sell, 1 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -100.0% | — |
| Next FY 2027-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 2 | 4 | 1 | 0% | |
| May 1, 2026 | 0 | 0 | 2 | 4 | 1 | 0% | |
| Apr 1, 2026 | 0 | 0 | 2 | 4 | 1 | 0% | |
| Mar 1, 2026 | 0 | 0 | 2 | 4 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 2 | 4 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.